Podiatric Medicine and Surgery Residency, Geisinger Community Medical Center, Scranton, Pennsylvania.
Musculoskeletal Institute, Geisinger Health System, Danville, Pennsylvania.
Int Wound J. 2019 Feb;16(1):250-255. doi: 10.1111/iwj.13019. Epub 2018 Nov 4.
Calciphylaxis is a rare and potentially fatal disease that affects the subcutaneous layer of the skin. It is a calcific vasculopathy induced by a systemic process that causes occlusion of small blood vessels. The mortality rate for individuals diagnosed with calciphylaxis is estimated between 52% and 81% with sepsis being the leading cause of death. Uraemic calciphylaxis and its known effective treatments are well documented in the literature. Unfortunately, there is no known effective treatment for non-uraemic calciphylaxis. Most of the current treatments for non-uraemic calciphylaxis are derived from uraemic calciphylaxis treatment protocols. We report a case of a 75-year-old female with calciphylaxis on the right lower extremity who was successfully treated with four pamidronate infusions in addition to local wound care. This case represents a non-uraemic calciphylaxis wound successfully treated with pamidronate infusions and standard wound care, and suggests that IV pamidronate can be an effective treatment option.
钙化防御是一种罕见且可能致命的疾病,影响皮肤的皮下层。它是一种由全身过程引起的钙化性血管病,导致小血管闭塞。诊断为钙化防御的个体的死亡率估计在 52%至 81%之间,其中脓毒症是主要死亡原因。尿毒症性钙化防御及其已知的有效治疗方法在文献中有详细记载。不幸的是,目前尚无针对非尿毒症性钙化防御的有效治疗方法。大多数非尿毒症性钙化防御的当前治疗方法源自尿毒症性钙化防御治疗方案。我们报告了一例 75 岁女性右下肢钙化防御病例,除局部伤口护理外,还成功接受了四次帕米膦酸盐输注治疗。该病例代表一例非尿毒症性钙化防御性伤口成功接受帕米膦酸盐输注和标准伤口护理治疗,提示 IV 帕米膦酸盐可能是一种有效的治疗选择。